Précédente
Catégorie - Politique, Approvisionnement
Nom de l'outil Measuring Transparency in the Public Pharmaceutical Sector
Sous-catégories VIH/SIDA, Paludisme, Santé reproductive, Tuberculose
types de produit Diagnostiques, Médicaments, Produits de santé reproductive
Date de mise à jour 2009
Version None
Développé par WHO/OMS
Quand l'utiliser Before, during or after procurement to identify vulnerability of the system to corruption and/or unethical practices.
Langues Anglais
Niveau d'utilisation Central, District, Régional
Forme PDF document, 1.4 MB - printed copies also available
Degré de formation ou d'assistance technique requis Training: 3 days. Technical assistance: 3 days. Feedback workshop: 2.5 days
Apports & Résultats Inputs: questionnaire forms on eight functions of the pharmaceutical system, independent national assessors, key informants. Outputs: level of transparency and vulnerability to corruption in the public pharmaceutical system, recommendations, policy guidance.
Coût Free
Advantages Provides evidence for advocating policy change in a sensitive area. Raises awareness of key informants and national team on forms and potential impact of corruption in their country. Provides solid basis for formulation of a national framework on good governance for medicines.
Contraintes Difficulty in identifying key informants and obtaining straightforward answers. Results may be biased if key informant selection is not appropriate (the instrument provides guidance). Assumption that greater transparency leads to less corruption.
Disponibilité http://www.who.int/medicines...ntInstrumentMeastranspENG.PDF
Remarques For more information contact WHO or visit: http://www.who.int/medicines/ggm
Contact ggminfo@who.int
Submission date 2010-07-06
Remarques
Pays
Remarque
Défi de calcul
afin d'éviter le Spam
Haut